Targeting autophagy using small-molecule compounds to improve potential therapy of Parkinson's

来源 :药学学报(英文版) | 被引量 : 0次 | 上传用户:flyhiger
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Parkinson\'s disease (PD),known as one of the most universal neurodegenerative diseases,is a serious threat to the health of the elderly.The current treatment has been demonstrated to relieve symp-toms,and the discovery of new small-molecule compounds has been regarded as a promising strategy.Of note,the homeostasis of the autolysosome pathway (ALP) is closely associated with PD,and impaired autophagy may cause the death of neurons and thereby accelerating the progress of PD.Thus,pharma-cological targeting autophagy with small-molecule compounds has been drawn a rising attention so far.In this review,we focus on summarizing several autophagy-associated targets,such as AMPK,mTORCl,ULK1,IMPase,LRRK2,beclin-l,TFEB,GCase,ERRα,C-Abelson,and as well as their relevant small-molecule compounds in PD models,which will shed light on a clue on exploiting more potential targeted small-molecule drugs tracking PD treatment in the near future.
其他文献
The three-dimensional (3D) conformation of chromatin is integral to the precise regulation of gene expression.The 3D genome and genomic variations in non-alcoholic fatty liver disease (NAFLD)are largely unknown,despite their key roles in cellular function
Receptor-interacting protein (RIP) kinase 1 is involved in immune-mediated inflammatory diseases including ulcerative colitis (UC) by regulating necroptosis and inflammation.Our group previ-ously identified TAK-632 (5) as an effective necroptosis inhibito
Programmed cell death ligand 1 (PD-L1)/programmed cell death protein 1 (PD-1) cascade is an effective therapeutic target for immune checkpoint blockade (ICB) therapy.Targeting PD-L1/PD-1 axis by small-molecule drug is an attractive approach to enhance ant
Pulmonary fibrosis (PF) is a chronic,progressive,fatal interstitial lung disease with limited available therapeutic strategies.We recently reported that the protein kinase glycogen synthase kinase-3β(GSK-3β) interacts with and inactivates the ubiquitin-ed
我国自1992年加入国际爱婴医院行动,已走过30年,经历了早期探索、早期创建、全面创建及复核创新阶段,拥有爱婴医院7000多所.爱婴医院创建行动对我国妇幼卫生工作起到积极推动作用,促进了保健与临床工作的结合,推动了妇幼卫生资源的合理利用,通过提升卫生保健服务质量保障我国妇女和儿童健康.随着时代发展与人民生活水平的提高,爱婴医院行动的服务内涵在不断延伸,如何应对我国爱婴医院行动中面临的诸多挑战,亟需总结以往经验,探索相应挑战的应对策略.
The integrity of lysosomes is of vital importance to survival of tumor ceils.We demonstrated that LW-218,a synthetic flavonoid,induced rapid lysosomal enlargement accompanied with lysosomal membrane permeabilization in hematological malignancy.LW-218-indu
Various boron-containing drugs have been approved for clinical use over the past two de-cades,and more are currently in clinical trials.The increasing interest in boron-containing compounds is due to their unique binding properties to biological targets;f
The TEA domain (TEAD) family proteins (TEAD1-4) are essential transcription factors that control cell differentiation and organ size in the Hippo pathway.Although the sequences and structures of TEAD family proteins are highly conserved,each TEAD isoform
目的 对围产期妇女进行以赋能为基础的综合干预指导,分析干预措施对促进母乳喂养的效果.方法 2019年6月-2020年12月在北京市通州区妇幼保健院建档的388例孕产妇作为干预组,在围产期进行母乳喂养指导、赋能教育和乳房保健,以同期385例初产妇为对照组,比较两组产妇母乳喂养的知识掌握情况、纯母乳喂养率的差异.结果 对纯母乳喂养时间为6个月的问题,两组在接受初次调查均知晓率高,其中干预组知晓率达93.81%(364/388),对照组92.46%(356/385);而对于哺乳技巧、哺乳期间常见问题处理措施等,
ERK pathway regulated the programmed death ligand-1 (PD-L1) expression which was linked to the response of programmed death-1 (PD-1)/PD-L1 blockade therapy.So it is deducible that ERK inhibitor could enhance the efficacy of PD-1 inhibitor in cancer immuno